All Type of News
Doctors oppose global budget payment scheme
The Korean Association of Obstetricians and Gynecologists and the government have clashed over a global budget payment scheme, under which medical fees for treatment of seven diseases will be fixed and covered by the ...
Ilyang shares boosted by new leukemia drug
Shares of Ilyang Pharmaceutical Co., a Korean drug developer, were boosted on Monday by expectations that its new leukemia treatment may help lift earnings in the second half of this year, analyst said.
Ilyang shar...
ED medication Zydena launched in Turkey
Dong-A Pharmaceutical Co. announced Monday that its erectile dysfunction (ED) drug Zydena (udenafil) has been marketed in Turkey, following Russia.
Under the terms of the agreement, Abdi Ibrahim Pharmaceuticals may...
Government to nurture 12 global pharmaceutical firms by 2020
The government unveiled a series of plans on Friday to support 12 globally competitive pharmaceutical companies by 2020.
The government will also support the establishment of two pharma-star graduate schools certif...
Restructuring lurks in pharmaceutical sector
Korea’s pharmaceutical sector is poised to head for a fresh round of restructuring, with many drug makers pushing employees to opt for early retirement plans amid growing worries over the lackluster earnings outlook d...
Drug companies squeezed by government
A chief executive of one of the leading drug companies in Korea expressed concern about the country’s pharmaceutical industry.
“We will have to make all-out to increase this year’s sales by at least 30 percent to m...
KPA executives under pressure to resign
The incumbent executives of the Korean Pharmaceutical association (KPA) is facing growing pressure to resign from pharmacists in Seoul after the KPA said on Dec. 22 that its members will agree with the government on s...
Hanmi’s IMD pidogul approved in Italy
Hanmi Pharmaceutical announced Monday that the firm received an approvable letter for Pidogul (clopidogrel napadisilate monohydrate) tablets, one of its incrementally modified drugs (IMDs), from Italian health authori...
Foreign drugmakers spur OTC sales
Multinational drug manufacturers, including Wyeth and Novartis, are focusing on boosting the sales of their flagship OTC (over-the-counter) drugs by offering a variety of incentives.
Facing the massive drug price c...
Health insurance posts surplus of 600 billion won in 2011
The national health insurance (NHI) recorded 600.8 billion won in the black last year, with its reserve of 1.56 trillion won, the Ministry of Health and Welfare said Thursday.
The ministry said that the National He...
